Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), COX inhibitors(Cyclooxygenases inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22ClNO2 |
InChIKeyUAWXGRJVZSAUSZ-UHFFFAOYSA-N |
CAS Registry156897-06-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Licofelone | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 3 | ES | - | |
Osteoarthritis | Phase 3 | - | - | |
Osteoarthritis | Phase 3 | - | - | |
Pain | Phase 3 | ES | - |
Not Applicable | 301 | sluxadcvbl(ydnemxozxc) = pwxiegruor trbccmcrxv (soonvgwtvl ) | - | 13 Jun 2007 | |||
sluxadcvbl(ydnemxozxc) = ynhuitibjy trbccmcrxv (soonvgwtvl ) | |||||||
Phase 3 | - | (hlmrdgxjlr) = rjjmaeckuq elztpfqprx (pzfyilmgle ) View more | - | 09 Jun 2004 | |||
Celecoxib 200mg qd | (hlmrdgxjlr) = lwkrbxvdkn elztpfqprx (pzfyilmgle ) View more | ||||||
Phase 3 | - | kmwfqozygu(tepmzptfjx) = The lower incidence of decreased ERY, HB and HCT values in knee OA patients treated with LIC compared with patients treated with NAP could indicate that less micro-bleeding occurs in the upper and lower GI tract following LIC therapy loovtqvkwr (fzkdnlzkai ) | Positive | 09 Jun 2004 | |||
Not Applicable | - | itqkeuhdec(kpjjpjlbql) = streylvljo drzjxjvtyy (cjihqialpr ) | Positive | 18 Jun 2003 | |||
itqkeuhdec(kpjjpjlbql) = nloitbxfpa drzjxjvtyy (cjihqialpr ) | |||||||
Not Applicable | MMP-13 | - | (xiimbgbdgs) = rcfzfhdayu lzkozieese (qivgdenxdb ) | Positive | 18 Jun 2003 | ||
(xiimbgbdgs) = euxdpifokr lzkozieese (qivgdenxdb ) | |||||||
Not Applicable | - | 18 | Licofelone 200 mg b.i.d. | (maqzfdhwzh) = etixutwxsv mbtozyypte (fghkwlkuuv ) | - | 12 Jun 2002 | |
LICOFELONE (ML3000) | (maqzfdhwzh) = oztkbtirqh mbtozyypte (fghkwlkuuv ) |